Do NK cells always need a license to kill?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. CXFrontiers in cellular and infection microbiology · 2021
   Article
2. Partial break in tolerance of NKG2ABone marrow transplantation · 2017
   Article
3. NK cell education via nonclassical MHC and non-MHC ligands.Cellular & molecular immunology · 2017
   Review
4. Hapten-induced contact hypersensitivity, autoimmune reactions, and tumor regression: plausibility of mediating antitumor immunity.Journal of immunology research · 2014
   Review
5. The role of natural killer cells in chronic myeloid leukemia.Revista brasileira de hematologia e hemoterapia · 2011
   Article
6. Surgery as a double-edged sword: a clinically feasible approach to overcome the metastasis-promoting effects of surgery by blunting stress and prostaglandin responses.Cancers · 2010
   Article

Corrections and comments

• Comment on
  'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection.2010

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as